Jazz Pharmaceuticals plc

NASDAQ: JAZZ
Share price (12/26/24): $125.82
Market cap (12/26/24): $7.606 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023 – amended

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Amendment to registration of securities for employees

Registration of securities for employees

Ownership Filter

News Filter

Change in Directors, Officers or Compensation

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Financial Statements or Exhibits

Announces U.S. FDA Approval of Ziihera® (Zanidatamab-Hrii) for the Treatment of Adults With Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer

Announces Third Quarter 2024 Financial Results

Termination of Material Definitive Agreement

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Confidential treatment order

Scanned paper annual report submission

Confidential treatment order

Confidential treatment order